ICU Medical, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2025: USD 638.34 M

ICU Medical, Inc. Selling, General, and Administrative Expenses (SG&A) is USD 638.34 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 4.34% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
  • ICU Medical, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 611.78 M, a 0.67% change year over year.
  • ICU Medical, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 607.71 M, a 58.50% change year over year.
  • ICU Medical, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 383.40 M, a 34.98% change year over year.
  • ICU Medical, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 284.04 M, a 2.67% change year over year.
Key Data
Date Selling, General, and Administrative Expenses (SG&A) Research and Development (R&D) Expenses Revenue Revenue